Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$16.60 USD
+0.16 (0.97%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $16.61 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
AVDL 16.60 +0.16(0.97%)
Will AVDL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AVDL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVDL
Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
Wall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Know
AVDL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Invest in Avadel (AVDL) Stock Now
Avadel (AVDL) is a Great Momentum Stock: Should You Buy?
How Much Upside is Left in Avadel (AVDL)? Wall Street Analysts Think 37.36%
Other News for AVDL
Avadel Pharmaceuticals to Join Russell 3000® Index
Avadel Pharmaceuticals Joins the Russell 3000® Index
Avadel Pharmaceuticals to join Russell 3000 index
Avadel Pharmaceuticals to join Russell 3000 Index
Jazz Pharmaceuticals: Pipeline Setback While Business Transition Continues